Clinical Trial Update: Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the addition of bevacizumab to chemotherapy for advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED